«These new results are significant because they represent the discovery of a number of more potent variations of the natural product
as cytotoxic agents against cancer cells,» Nicolaou said.
Not exact matches
Currently inhaled non-specific
cytotoxic agents have been evaluated
as a future treatment for local disease control and distant metastasis control.
This study illustrates the potential benefits of using GHRH antagonists for the treatment of cancers that are highly resistant to
cytotoxic agents such
as doxorubicin.
The control of these conditions often involves the long - term use of corticosteroids and other drugs such
as immunosuppressive or
cytotoxic agents.